Dig Dis Sci. 2021 May 30; doi: 10.1007/s10620-021-07074-3. Epub 2021 May 30.

Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.

Digestive diseases and sciences

L Servais, G Boschetti, C Meunier, C Gay, E Cotte, Y François, A Rozieres, J Fontaine, L Cuminal, M Chauvenet, A L Charlois, S Isaac, A Traverse-Glehen, X Roblin, B Flourié, P J Valette, S Nancey

PMID: 34052948 DOI: 10.1007/s10620-021-07074-3

Abstract

BACKGROUND AND AIMS: Contrast-enhanced ultrasonography (CEUS) is a potential interesting method for assessing accurately Crohn's disease (CD) activity. We compared the value of intestinal ultrasonography (US) coupled with contrast agent injection with that of magnetic resonance enterography (MRE) in the assessment of small bowel CD activity using surgical histopathology analysis as reference.

METHODS: Seventeen clinically active CD patients (14 women, mean age 33 years) requiring an ileal or ileocolonic resection were prospectively enrolled. All performed a MRE and a US coupled with contrast agent injection (CEUS) less than 8 weeks prior to surgery. Various imaging qualitative and quantitative parameters were recorded and their respective performance to detect disease activity, disease extension and presence of complications was compared to surgical histopathological analysis.

RESULTS: The median wall thickness measured by US differed significantly between patients with non-severely active CD (n = 5) and those with severely active CD (n = 12) [7.0 mm, IQR (6.5-9.5) vs 10.0 mm, IQR (8.0-12.0), respectively; p = 0.03]. A non-significant trend was found with MRE with a median wall thickness in severe active CD of 10.0 mm, IQR (8.0-13.7) compared with 8.0 mm, IQR (7.5-10.5) in non-severely active CD (p = 0.07). The area under the ROC curve (AUROC) of the wall thickness assessed by US and MRE to identify patients with or without severely active CD on surgical specimens were 0.85, 95% CI (0.64-1.04), p = 0.03 and 0.80, 95% CI (0.56-1.01), p = 0.07, respectively. Among the parameters derived from the time-intensity curve during CEUS, time to peak and rise time were the two most accurate markers [AUROC = 0.88, 95% CI (0.70-1.04), p = 0.02 and 0.86, 95% CI (0.68-1.04), p = 0.03] to detect patients with severely active CD assessed on surgical specimens.

CONCLUSION: The accuracy of intestinal CEUS is close to that of conventional US to detect disease activity. A thickened bowel and shortened time to peak and rise time were the most accurate to identify CD patients with severe histological disease activity.

Keywords: CEUS; Complication; Crohn’s disease; Inflammation; MRE; Pathology; Preoperative assessment

References

1. Gomollon F, Dignass A, Annese V et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis 2016;11:3–25. - PubMed
2. Chiorean MV, Sandrasegaran K, Saxena R et al. Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol 2007;102:2541–2550. - PubMed
3. Rimola J, Rodriguez S, García-Bosch O et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 2009;58:1113–1120. - PubMed
4. Maaser C, Sturm A, Vavricka SR et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019;13:144–164. - PubMed
5. Nylund K, Hausken T, Gilja O-H. Ultrasound and inflammatory bowel disease. Ultrasound Q 2010;26:3–15. - PubMed
6. Martinez M, Ripollés T, Paredes JM et al. Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRI. Abdom Imaging 2009;34:141–148. - PubMed
7. Novak KL, Kaplan G, Panaccione R et al. A simple ultrasound score for the accurate detection of inflammatory activity in Crohn’s disease. Inflamm Bowel Dis 2017;23:2001–2010. - PubMed
8. Buisson A, Gonzalez F, Poullenot F et al. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflamm Bowel Dis 2017;23:1425–1433. - PubMed
9. Migaleddu V, Scanu AM, Quaia E et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn’s disease. Gastroenterology 2009;137:43–52. - PubMed
10. Medellin-Kowalewski A, Wilkens R, Wilson A et al. Quantitative contrast-enhanced ultrasound parameters in Crohn’s disease: their role in disease activity determination with ultrasound. Am J Roentgenol 2016;206:64–73. - PubMed
11. Ripollés T, Martinez M, Paredes JM et al. Crohn’s disease : correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 2009;253:241–248. - PubMed
12. Ripollés T, Rausell N, Paredes JM et al. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohns Colitis 2013;7:120–128. - PubMed
13. Quaia E. Contrast-enhanced ultrasound of the small bowel in Crohn’s disease. Abdom Imaging 2013;38:1005–1013. - PubMed
14. Horjus Talabur Horje CS, Bruijnen R, Roovers L et al. Contrast-enhanced abdominal ultrasound in the assessment of ileal inflammation in Crohn’s disease: a comparison with MR enterography. PLoS ONE 2015;10:e0136105. - PubMed
15. Ripollés T, Martinez-Perez M, Paredes JM et al. The role of intravenous contrast agent in the sonographic assessment of Crohn’s disease activity: is contrast agent injection necessary? J Crohns Colitis 2019;13:585–592. - PubMed
16. Romanini L, Passamonti M, Navarria M et al. Quantitative analysis of contrast-enhanced ultrasonography of the bowel wall can predict disease activity in inflammatory bowel disease. Eur J Radiol 2014;83:1317–1323. - PubMed
17. Zappa M, Stefanescu C, Cazals-Hatem D et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011;17:984–993. - PubMed
18. Girlich C, Jung EM, Huber E et al. Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn’s disease. Ultraschall Med 2011;32:154–159. - PubMed
19. Wilkens R, Hagemann-Madsen RH, Peters DA et al. Validity of contrast-enhanced ultrasonography and dynamic contrast-enhanced MR enterography in the assessment of transmural activity and fibrosis in Crohn’s disease. J Crohns Colitis 2018;12:48–56. - PubMed
20. Tielbeek JAW, Ziech MLW, Li Z et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol 2014;24:619–629. - PubMed
21. Castiglione F, Mainenti PP, De Palma GD. Noninvasive diagnosis of small bowel Crohn’s disease: direct comparison of bowel sonography and magnetic resonance enterography. Inflamm Bowel Dis 2013;19:991–998. - PubMed
22. Maconi G, Asthana AK, Bolzacchini E et al. Splanchnic hemodynamics and intestinal vascularity in Crohn’s disease: an in vivo evaluation using doppler and contrast-enhanced ultrasound and biochemical parameters. Ultrasound Med Biol 2016;42:150–158. - PubMed
23. Brahme F, Lindstrom C. A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn’s disease and ulcerative colitis. Gut 1970;11:928–940. - PubMed
24. Drews BH, Barth TF, Hanle MM et al. Comparison of sonographically measured bowel wall vascularity, histology and disease activity in Crohn’s disease. Eur Radiol 2009;19:1379–1386. - PubMed
25. Deray G, Rouviere O, Bacigalupo L et al. Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study). Eur Radiol 2013;23:1250–1259. - PubMed
26. Kim K-J, Lee Y, Park SH et al. Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis 2015;21:101–109. - PubMed
27. Wilkens R, Peters DA, Nielsen AH et al. Dynamic contrast-enhanced magnetic resonance enterography and dynamic contrast-enhanced ultrasonography in Crohn’s disease: an observational comparison study. Ultrasound Int Open 2017;3:E13–E24. - PubMed

Publication Types

• Journal Article